financetom
Business
financetom
/
Business
/
Salesforce Insider Sold Shares Worth $1,213,055, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce Insider Sold Shares Worth $1,213,055, According to a Recent SEC Filing
Oct 23, 2024 12:52 AM

03:23 AM EDT, 10/23/2024 (MT Newswires) -- Parker Harris, Director, Co-Founder and Chief Technology Officer, Slack, on October 22, 2024, sold 4,200 shares in Salesforce ( CRM ) for $1,213,055. Following the Form 4 filing with the SEC, Harris has control over a total of 1,926,992 shares of the company, with 118,514 shares held directly and 1,808,478 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1108524/000112760224025867/xslF345X05/form4.xml

Price: 288.25, Change: -0.08, Percent Change: -0.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quantum computing startup QuEra closes $230 million funding round
Quantum computing startup QuEra closes $230 million funding round
Feb 11, 2025
(Removes extraneous word in the headline) (Reuters) - QuEra Computing said on Tuesday the neutral-atom quantum firm has completed a funding round in excess of $230 million, with investment from Google's Quantum AI business unit and SoftBank Vision Fund, among others. The valuation of the company at which it raised the money was not disclosed. Neutral-atom quantum computing makes it...
BRIEF-nCino Acquires Sandbox Banking
BRIEF-nCino Acquires Sandbox Banking
Feb 11, 2025
Feb 11 (Reuters) - nCino: * NCINO ACQUIRES SANDBOX BANKING TO HELP FINANCIAL INSTITUTIONS ACHIEVE BETTER DATA ALIGNMENT AND SYSTEM INTEROPERABILITY * NCINO INC ( NCNO ) - DEAL VALUED AT $52.5 MILLION WITH $10 MILLION EARN-OUT OPPORTUNITY Source text: Further company coverage: ...
Regeneron Pharmaceuticals' Blood Cancer Drug Application Accepted by FDA
Regeneron Pharmaceuticals' Blood Cancer Drug Application Accepted by FDA
Feb 11, 2025
07:58 AM EST, 02/11/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Tuesday that the US Food and Drug Administration has accepted for review the resubmission of the biologics license application for linvoseltamab as a potential the treatment for adult patients with relapsed or refractory multiple myeloma. The indication is specifically for patients who have received at least four...
Exclusive-LVMH media unit refrains from lawsuit against Musk-owned X - sources
Exclusive-LVMH media unit refrains from lawsuit against Musk-owned X - sources
Feb 11, 2025
PARIS - LVMH-owned newspaper group Les Echos-Le Parisien is not party to a lawsuit involving French media against Elon Musk's X that it previously said it would join, according to a court official, and four media industry sources said the LVMH papers no longer planned to sue the platform.   Les Echos-Le Parisien and other French newspapers, including publications owned by...
Copyright 2023-2025 - www.financetom.com All Rights Reserved